Skip to main content

Shingles and your immunocompromised patients: Risk, burden and management

Shingles and your immunocompromised patients: Risk, burden and management

Session Date:

Immunocompromised patients are at increased risk of herpes zoster (shingles) and its complications, resulting in significant clinical burden and impact on quality of life.

In this session, Dr Hasan Bhally will provide a clinically focused overview of shingles risk and disease burden in immunocompromised adults, with specific relevance to the New Zealand primary care setting.

This lunch session is sponsored by:

GSK